Stemtech Corporation and Seacret Direct, LLC (VIÁGO), have agreed to merge their businesses. Stemtech CEO and Chairman Charles S. Arnold will continue as Chairman of the holding company, while VIÁGO CEO Izhak Ben Shabat will serve as CEO. Eddie Head, originally from VIÁGO, will now be the President and Chief Strategy Officer. John W. Meyer, from Stemtech, will be President and Chief Operating Officer.
“This union positions us for accelerated growth and brings substantial value to our shareholders,” Arnold said. “Together, we are building a stronger future for our combined companies and their subsidiaries. The merger creates an exciting future for VIÁGO and Stemtech, uniting our strengths and offering greater opportunities for our members, customers, and affiliates. This is a partnership rooted in mutual growth and shared vision.”
VIÁGO was established to help members live their best life and leads with the slogan “Life amplified.” Stemtech is a leader in all-natural plant-based stem cell nutrition, called stemceuticals, which has generated approximately $600 million in revenue.
“This unites two well-established companies in a public forum, maximizing value for stakeholders, customers, affiliates, and shareholders alike,” Shabat said. “It also empowers the community to share in the company’s global growth and success.”
Both companies will maintain their individual channels to ensure continuity for consumers.
